
生命科学领域的AI:重新构想人类健康的未来
未来十年,生物学和计算技术深刻融合,彻底改变人类健康。曾经仅存在于设想中的进展,已逐渐成长为实际的工具,推动医疗保健从被动治疗转向预测性、个性化和预防性的模式。生物学和技术的变革为重塑医学的未来创造了机会,但同时也引发了深刻的伦理问题。
Accomplished venture capital investor with a proven track record. Focusing on AI + Life Science/Healthcare. Extensive network spans across senior executives, academic leaders and syndicate investors. She is also a passionate venture builder with solid 0-to-1 incubation experience, taking innovations from patents to market by designing strategies, supporting capital raises and assembling high-performing teams. Before her venture capital career, Qing was a physician at Singapore General Hospital and a researcher at Broad Institute. She holds M.D. at Tsinghua University and MBA from Columbia Business School.
未来十年,生物学和计算技术深刻融合,彻底改变人类健康。曾经仅存在于设想中的进展,已逐渐成长为实际的工具,推动医疗保健从被动治疗转向预测性、个性化和预防性的模式。生物学和技术的变革为重塑医学的未来创造了机会,但同时也引发了深刻的伦理问题。
La IA generativa en las ciencias de la vida nos está ayudando a reimaginar el futuro de la salud humana, creando atención predictiva y preventiva.
GenAI in life sciences is helping us reimagine the future of human health, building predictive and preventive care while also raising ethical questions.
